Table 1. The role of fibroblasts in different types of neurogenic tumors.
Neurogenic tumors | Directions of update studies | Current findings of fibroblasts promoting neurogenic tumors | Related other stroma cells | Relations between these cells | References |
---|---|---|---|---|---|
Neuroblastoma | Angiogenesis; inflammation; tumor metabolism | Angiogenesis: cancer-associated fibroblasts and high blood vessel growth in Schwannian stroma-poor neuroblastomas | Schwann cells | Schwann cells might inhibit the activation and promoting angiogenesis functions of fibroblasts | (22,24,25,31,34-37) |
Inflammation: fibroblasts with activation of mPGES-1/PGE2 were found essential in neuroblastoma growth and development | |||||
Tumor metabolism: SDHB-silenced tumor cells showed a significant increase in lactate uptake, a decrease in glucose uptake | |||||
Pheochromocytomas | Tumor metabolism; inflammation | Sdhb-silenced tumor cells co-cultured with fibroblasts implicated the fibroblasts might function by mobilization of energy resources to tumor migration | – | – | (27,32,33) |
Fibroblasts-secreted IGF-1 plays an essential role in the early events of cell anchorage and genesis | |||||
Neurofibromatosis type 1 | Collagens secret | Activated mast cells secreted 2.5-fold TGF-β to potentiate the fibroblasts, which secreted a large amount of collagen accounting for half of the dry weight of neurofibroma | Mast cells | Mast cells secret 2.5-fold TGF-β and potentiate Nf1+/− fibroblasts functions | (42-45) |
MPNST | Fibroblastic differentiation | Some MPNST cases showed positive CD34 expression, indicating fibroblastic features in MPNST | – | – | (49-51) |
mPGES-1/PGE2, microsomal prostaglandin E synthase-1/prostaglandin E2; SDHB, succinate dehydrogenase subunits B; IGF-1, insulin-like growth factor 1; TGF-β, transforming growth factor β; MPNST, malignant peripheral nerve sheath tumors; CD34, cell differentiation factor 34.